Author(s): Timothy Hughes, Carla Boquimpani, Naoto Takahashi, et al Abstract: P 257 Session topic: 8. Chronic myeloid leukemia – Clinical Background: ENESTop (NCT01698905) is evaluating the ability to stop treatment and remain in TFR in pts with CML-CP who achieved a sustained deep molecular response (MR) after switching from imatinib (IM) to...
Pro zobrazení tohoto obsahu je třeba být přihlášen.